{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:14Z","timestamp":1772165654475,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Altered fat distribution and chronic inflammation are found in both persons living with HIV (PLWH) and persons with diabetes mellitus type 2 (DM2) and are known risk factors for cardiovascular diseases (CVD). We aimed to investigate if a synergistic effect of HIV infection and DM2 was found on fat distribution and inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was performed including PLWH with HIV RNA &lt;\u2009200 copies\/mL (18 with DM2 (HIV\u2009+\u2009DM2+), 18 without DM2 (HIV\u2009+\u2009DM2-)) and controls (19 with DM2 (controls with DM2) and 25 without DM2 (healthy controls). We measured fat distribution using dual-energy X-ray absorptiometry scan. Plasma concentrations of adiponectin, interleukin-6 (IL-6), tumor necrosis factor-alfa (TNF-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      ) and soluble CD14 (sCD14) was measured using snap-frozen plasma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HIV\u2009+\u2009DM2+ and HIV\u2009+\u2009DM2- had comparable trunk\/limb fat ratio. In contrast, HIV\u2009+\u2009DM2+ had a higher trunk\/ limb fat ratio than controls with DM2 and healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). However, HIV\u2009+\u2009DM2+ and controls with DM2 had comparable amount of trunk fat mass (kg) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.254). A lower concentration of plasma adiponectin and higher concentration of IL-6 was found in HIV\u2009+\u2009DM2+ than in HIV\u2009+\u2009DM2-(\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039) and in healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012). In contrast, plasma adiponectin and IL-6 concentrations were comparable in HIV\u2009+\u2009DM2+ and controls with DM2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.345 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.825). Concentration of sCD14 was comparable in HIV\u2009+\u2009DM2+ and HIV\u2009+\u2009DM2\u2013(\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.850), but elevated in HIV\u2009+\u2009DM2+ compared to controls with DM2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). No statistical interactions were found between HIV infection and DM2 for any of the depending variables.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A synergistic effect of HIV and DM2 was not found for any of the outcomes. However, HIV\u2009+\u2009DM2+ had features related to both HIV infection and DM2 with a high trunk\/limb ratio, high trunk fat mass, low concentration of plasma adiponectin and elevated concentrations of IL-6 and sCD14. This could contribute to elevated risk of CVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05594-3","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T07:05:53Z","timestamp":1606287953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers"],"prefix":"10.1186","volume":"20","author":[{"given":"Malene","family":"Hove-Skovsgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Abildgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gelpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Christine","family":"Gaardbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Kolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Tr\u00f8seid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitte","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-7455","authenticated-orcid":false,"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"5594_CR1","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1086\/652283","volume":"50","author":"The Antiretroviral Therapy Cohort Collaboration","year":"2010","unstructured":"The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1\u2013infected patients treated with antiretroviral therapy, 1996\u20132006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50:1387\u201396. https:\/\/doi.org\/10.1086\/652283.","journal-title":"Clin Infect Dis"},{"key":"5594_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/QAI.0000000000000825","volume":"71","author":"RA Legarth","year":"2016","unstructured":"Legarth RA, Ahlstr\u00f6m MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Long-term mortality in HIV-infected individuals 50 years or older: a Nationwide, population-based cohort study. Jaids. 2016;71:213\u20138. https:\/\/doi.org\/10.1097\/QAI.0000000000000825.","journal-title":"Jaids"},{"key":"5594_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","volume":"173","author":"MS Freiberg","year":"2013","unstructured":"Freiberg MS, Chang C-CH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614\u201322. https:\/\/doi.org\/10.1001\/jamainternmed.2013.3728.","journal-title":"JAMA Intern Med"},{"key":"5594_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","volume":"13","author":"FM Islam","year":"2012","unstructured":"Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13:453\u201368.","journal-title":"HIV Med"},{"key":"5594_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/QAD.0000000000002119","volume":"33","author":"M Gelpi","year":"2019","unstructured":"Gelpi M, Afzal S, Fuchs A, Lundgren J, Knudsen AD, Drivsholm N, et al. Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors. AIDS. 2019;33:675\u201383.","journal-title":"AIDS."},{"key":"5594_CR6","doi-asserted-by":"publisher","first-page":"ofu040","DOI":"10.1093\/ofid\/ofu040","volume":"1","author":"B Hasse","year":"2014","unstructured":"Hasse B, Iff M, Ledergerber B, Calmy A, Schmid P, Hauser C, et al. Obesity trends and body mass index changes after starting antiretroviral treatment: the Swiss HIV cohort study. Open forum Infect Dis. 2014;1:ofu040. https:\/\/doi.org\/10.1093\/ofid\/ofu040.","journal-title":"Open forum Infect Dis"},{"key":"5594_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/QAI.0000000000001071","volume":"73","author":"M Herrin","year":"2016","unstructured":"Herrin M, Connecticut BAVA, System H, Haven W, Tate JP, Va SD, et al. Weight gain and incident diabetes among HIV infected-veterans initiating antiretroviral therapy compared to uninfected individuals. JAIDS J Acquir Immune Defic Syndr. 2016;73:228\u201336.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"4","key":"5594_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/hiv.12294","volume":"17","author":"A Achhra","year":"2015","unstructured":"Achhra A, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, et al. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:a: D study. HIV Med. 2015;17(4):255. https:\/\/doi.org\/10.1111\/hiv.12294.","journal-title":"HIV Med"},{"key":"5594_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/1471-2334-14-347","volume":"14","author":"P Freitas","year":"2014","unstructured":"Freitas P, Carvalho D, Santos AC, Madureira AJ, Martinez E, Pereira J, et al. Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome. BMC Infect Dis. 2014;14:347. https:\/\/doi.org\/10.1186\/1471-2334-14-347.","journal-title":"BMC Infect Dis"},{"key":"5594_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.2009.976","volume":"302","author":"S Li","year":"2009","unstructured":"Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302:179\u201388.","journal-title":"JAMA."},{"key":"5594_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/QAD.0000000000000186","volume":"28","author":"KS Ketlogetswe","year":"2014","unstructured":"Ketlogetswe KS, Post WS, Li X, Palella FJ, Jacobson LP, Margolick JB, et al. Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men. AIDS. 2014;28:901\u20139. https:\/\/doi.org\/10.1097\/QAD.0000000000000186.","journal-title":"AIDS."},{"key":"5594_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2337\/diabetes.54.2.534","volume":"54","author":"MB Schulze","year":"2005","unstructured":"Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005;54:534\u20139. https:\/\/doi.org\/10.2337\/diabetes.54.2.534.","journal-title":"Diabetes."},{"key":"5594_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","volume":"29","author":"NI Wada","year":"2015","unstructured":"Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015;29:463\u201371.","journal-title":"AIDS"},{"key":"5594_CR14","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1086\/652749","volume":"201","author":"J Neuhaus","year":"2010","unstructured":"Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201:1788\u201395. https:\/\/doi.org\/10.1086\/652749.","journal-title":"J Infect Dis"},{"key":"5594_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98\u2013107. https:\/\/doi.org\/10.1038\/nri2925.","journal-title":"Nat Rev Immunol"},{"key":"5594_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2334-8","volume":"17","author":"M Hove-Skovsgaard","year":"2017","unstructured":"Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, et al. HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation. BMC Infect Dis. 2017;17:1\u20138.","journal-title":"BMC Infect Dis"},{"key":"5594_CR17","volume-title":"Defintion and diagnosis diabetes Mellistus and Iintermediate hyperglycemia","author":"Geneva: World Health Organization","year":"2006","unstructured":"Geneva: World Health Organization. Defintion and diagnosis diabetes Mellistus and Iintermediate hyperglycemia; 2006."},{"key":"5594_CR18","unstructured":"Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26158184."},{"key":"5594_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/dom.13198","volume":"20","author":"KM Winding","year":"2018","unstructured":"Winding KM, Munch GW, Iepsen UW, Van Hall G, Pedersen BK, Mortensen SP. The effect on glycaemic control of low-volume high-intensity interval training versus endurance training in individuals with type 2 diabetes. Diabetes Obes Metab. 2018;20:1131\u20139.","journal-title":"Diabetes Obes Metab"},{"key":"5594_CR20","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487\u201395 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15161807.","journal-title":"Diabetes Care"},{"key":"5594_CR21","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"A Carr","year":"2003","unstructured":"Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG, et al. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet. 2003;361:726\u201335 http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=emed6&NEWS=N&AN=2003105925.","journal-title":"Lancet"},{"key":"5594_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/09540121.2010.543885","volume":"23","author":"JE Lake","year":"2011","unstructured":"Lake JE, Wohl D, Scherzer R, Grunfeld C, Tien PC, Sidney S, et al. Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care. 2011;23:929\u201338. https:\/\/doi.org\/10.1080\/09540121.2010.543885.","journal-title":"AIDS Care"},{"key":"5594_CR23","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","volume":"29","author":"GR Hajer","year":"2008","unstructured":"Hajer GR, Van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959\u201371.","journal-title":"Eur Heart J"},{"key":"5594_CR24","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1097\/QAD.0000000000000817","volume":"29","author":"LJ Conley","year":"2015","unstructured":"Conley LJ, Bush TJ, Rupert AW, Sereti I, Patel P, Brooks JT, et al. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy. Aids. 2015;29:2201\u20137.","journal-title":"Aids."},{"key":"5594_CR25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4049\/jimmunol.144.2.480","volume":"144","author":"EC Breen","year":"1990","unstructured":"Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol. 1990;144:480\u20134 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2295799.","journal-title":"J Immunol"},{"key":"5594_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.286.1.64","volume":"286","author":"MA Albert","year":"2001","unstructured":"Albert MA, Danielson E, Rifai N, Ridker PM, for the PRINCE Investigators. Effect of statin therapy on C-reactive protein levels. JAMA. 2001;286:64. https:\/\/doi.org\/10.1001\/jama.286.1.64.","journal-title":"JAMA"},{"key":"5594_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2016.07.897","volume":"253","author":"P Chru\u015bciel","year":"2016","unstructured":"Chru\u015bciel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194\u2013208.","journal-title":"Atherosclerosis."},{"key":"5594_CR28","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1097\/QAI.0000000000002124","volume":"82","author":"RJ Bedimo","year":"2019","unstructured":"Bedimo RJ, Mar H, Bosch RJ, Drechsler H, Cyktor JC, Macatangay BJC, et al. Brief report: no evidence for an association between statin use and lower biomarkers of HIV persistence or immune activation\/inflammation during effective ART. J Acquir Immune Defic Syndr. 2019;82:e27\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5594_CR29","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/infdis\/jiu012","volume":"209","author":"AR Eckard","year":"2014","unstructured":"Eckard AR, Jiang Y, Debanne SM, Funderburg NT, Mccomsey GA. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy. J Infect Dis. 2014;209:1156\u201364.","journal-title":"J Infect Dis"},{"key":"5594_CR30","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jdiacomp.2016.05.022","volume":"31","author":"M Mazidi","year":"2017","unstructured":"Mazidi M, Karimi E, Rezaie P, Ferns GA. Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Complicat. 2017;31:1237\u201342. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.05.022.","journal-title":"J Diabetes Complicat"},{"key":"5594_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/infdis\/jiv123","volume":"212","author":"\u00c1H Borges","year":"2015","unstructured":"Borges \u00c1H, O\u2019Connor JL, Phillips AN, R\u00f6nsholt FF, Pett S, Vjecha MJ, et al. Factors associated with plasma IL-6 levels during HIV infection. J Infect Dis. 2015;212:585\u201395. https:\/\/doi.org\/10.1093\/infdis\/jiv123.","journal-title":"J Infect Dis"},{"key":"5594_CR32","doi-asserted-by":"publisher","first-page":"e000844","DOI":"10.1161\/JAHA.114.000844","volume":"3","author":"AD Nordell","year":"2014","unstructured":"Nordell AD, McKenna M, Borges \u00c1H, Duprez D, Neuhaus J, Neaton JD. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014;3:e000844. https:\/\/doi.org\/10.1161\/JAHA.114.000844.","journal-title":"J Am Heart Assoc"},{"key":"5594_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/QAI.0b013e31825b03be","volume":"60","author":"RC Kaplan","year":"2012","unstructured":"Kaplan RC, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, et al. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. JAIDS J Acquir Immune Defic Syndr. 2012;60:359\u201368. https:\/\/doi.org\/10.1097\/QAI.0b013e31825b03be.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"5594_CR34","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/QAD.0000000000000735","volume":"29","author":"CL Shive","year":"2015","unstructured":"Shive CL, Jiang W, Anthony DD, Lederman MM. Soluble CD14 is a nonspecific marker of monocyte activation. AIDS. 2015;29:1263\u20135. https:\/\/doi.org\/10.1097\/QAD.0000000000000735.","journal-title":"AIDS."},{"key":"5594_CR35","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1182\/blood.V92.6.2084","volume":"92","author":"E Lien","year":"1998","unstructured":"Lien E, Aukrust P, Sundan A, M\u00fcller F, Fr\u00f8land SS, Espevik T. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood. 1998;92:2084\u201392 http:\/\/www.bloodjournal.org\/content\/92\/6\/2084.abstract.","journal-title":"Blood."},{"key":"5594_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/B978-0-12-407707-2.00002-3","volume":"191","author":"MM Lederman","year":"2013","unstructured":"Lederman MM, Funderburg NT, Sekaly RP, Klatt NR, Hunt PW. Residual immune Dysregulation syndrome in treated HIV infection. J Infect Dis. 2013;191:51\u201383. https:\/\/doi.org\/10.1016\/B978-0-12-407707-2.00002-3.","journal-title":"J Infect Dis"},{"key":"5594_CR37","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2337\/dc10-1676","volume":"34","author":"PJ Pussinen","year":"2011","unstructured":"Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care. 2011;34:392\u20137. https:\/\/doi.org\/10.2337\/dc10-1676.","journal-title":"Diabetes Care"},{"key":"5594_CR38","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/QAI.0000000000001444","volume":"75","author":"BS Taylor","year":"2017","unstructured":"Taylor BS, So-Armah K, Tate JP, Marconi VC, Koethe JR, Bedimo RJ, et al. HIV and obesity comorbidity increase interleukin 6 but not soluble CD14 or D-dimer. J Acquir Immune Defic Syndr. 2017;75:500\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5594_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/infdis\/jiw096","volume":"214","author":"V Mave","year":"2016","unstructured":"Mave V, Erlandson KM, Gupte N, Balagopal A, Asmuth DM, Campbell TB, et al. Inflammation and change in body weight with antiretroviral therapy initiation in a multinational cohort of HIV-infected adults. J Infect Dis. 2016;214:65\u201372.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05594-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T21:17:40Z","timestamp":1723929460000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05594-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5594"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05594-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.16322\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.16322\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.16322\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and approved by the local ethical committee on health research ethics, \u201cVidenskabsetisk Komitee, Region Hovedstaden\u201d which belongs to The Danish National Committee on Health Research Ethics (H-4-2012-076 CIM VEK) and the Danish Data Protection Agency. All participants signed a written consent when included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MG: unrestricted travel grants from Gilead; SDN: Unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, Rigshospitalet Research Council. Travelling grants from Gilead and GSK\/ViiV. Advisory board activity for Gilead and GSK\/ViiV. All other authors have no competing interests. Part of the data were presented as a poster presentation at Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, February 23 to February 26, 2015.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"882"}}